A method for killing larvae of oestrus ovis parasitizing in the nasal cavity of bactrian camel
By injecting drugs at the junction of the nasal bone, maxilla, and frontal bone of Bactrian camels, the problem of traditional nostril administration being unable to eliminate the first-stage larvae of the camel-headed fly was solved, achieving direct pest control of overwintering larvae and reducing disease damage and economic losses.
Patent Information
- Application Number
- CN202410949199.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2025-12-26
- Estimated Expiration
- 2044-07-16
AI Technical Summary
Existing technologies are insufficient to effectively eliminate the first-stage larvae of the camel-headed fly that parasitize the nasal cavity of Bactrian camels, especially during the overwintering period, through traditional nostril-administered medication.
By using a disposable syringe to vertically and obliquely inject the drug at the non-bone soft tissue junction where the nasal bone, maxilla, and frontal bone of the Bactrian camel meet, the insecticide is directly delivered into the internal nasal turbinate bone, thereby eliminating the first-stage larvae of the overwintering camel-headed fly.
It achieved direct pest control of the first-stage larvae of the wintering camel-headed fly, reducing the harm of diseases caused by parasites and lowering economic losses.